Perindopril effective in `real world' setting

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2002

Schlagwörter:	Perindopril Oral Antihyperglycaemic Agent Perindopril Erbumine Aceon Erbumine

Anmerkung:	© Adis International Ltd 2002

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1341(2002), 1 vom: Juni, Seite 13-15
Übergeordnetes Werk:	volume:1341 ; year:2002 ; number:1 ; month:06 ; pages:13-15

Links:	Volltext

DOI / URN:	10.2165/00128413-200213410-00024

Katalog-ID:	SPR035130539

Internformat


LEADER	01000caa a22002652 4500
001	SPR035130539
003	DE-627
005	20230519142030.0
007	cr uuu---uuuuu
008	201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200213410-00024 \|2 doi
035			\|a (DE-627)SPR035130539
035			\|a (SPR)00128413-200213410-00024-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Perindopril effective in `real world' setting
264		1	\|c 2002
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2002
650		4	\|a Perindopril \|7 (dpeaa)DE-He213
650		4	\|a Oral Antihyperglycaemic Agent \|7 (dpeaa)DE-He213
650		4	\|a Perindopril Erbumine \|7 (dpeaa)DE-He213
650		4	\|a Aceon \|7 (dpeaa)DE-He213
650		4	\|a Erbumine \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1341(2002), 1 vom: Juni, Seite 13-15 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1341 \|g year:2002 \|g number:1 \|g month:06 \|g pages:13-15
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200213410-00024 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 1341 \|j 2002 \|e 1 \|c 06 \|h 13-15

Indexfelder

matchkey_str	article:22306056:2002----::eidpiefcienel
hierarchy_sort_str	2002
publishDate	2002
allfields	10.2165/00128413-200213410-00024 doi (DE-627)SPR035130539 (SPR)00128413-200213410-00024-e DE-627 ger DE-627 rakwb eng Perindopril effective in `real world' setting 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Perindopril (dpeaa)DE-He213 Oral Antihyperglycaemic Agent (dpeaa)DE-He213 Perindopril Erbumine (dpeaa)DE-He213 Aceon (dpeaa)DE-He213 Erbumine (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1341(2002), 1 vom: Juni, Seite 13-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1341 year:2002 number:1 month:06 pages:13-15 https://dx.doi.org/10.2165/00128413-200213410-00024 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1341 2002 1 06 13-15
spelling	10.2165/00128413-200213410-00024 doi (DE-627)SPR035130539 (SPR)00128413-200213410-00024-e DE-627 ger DE-627 rakwb eng Perindopril effective in `real world' setting 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Perindopril (dpeaa)DE-He213 Oral Antihyperglycaemic Agent (dpeaa)DE-He213 Perindopril Erbumine (dpeaa)DE-He213 Aceon (dpeaa)DE-He213 Erbumine (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1341(2002), 1 vom: Juni, Seite 13-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1341 year:2002 number:1 month:06 pages:13-15 https://dx.doi.org/10.2165/00128413-200213410-00024 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1341 2002 1 06 13-15
allfields_unstemmed	10.2165/00128413-200213410-00024 doi (DE-627)SPR035130539 (SPR)00128413-200213410-00024-e DE-627 ger DE-627 rakwb eng Perindopril effective in `real world' setting 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Perindopril (dpeaa)DE-He213 Oral Antihyperglycaemic Agent (dpeaa)DE-He213 Perindopril Erbumine (dpeaa)DE-He213 Aceon (dpeaa)DE-He213 Erbumine (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1341(2002), 1 vom: Juni, Seite 13-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1341 year:2002 number:1 month:06 pages:13-15 https://dx.doi.org/10.2165/00128413-200213410-00024 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1341 2002 1 06 13-15
allfieldsGer	10.2165/00128413-200213410-00024 doi (DE-627)SPR035130539 (SPR)00128413-200213410-00024-e DE-627 ger DE-627 rakwb eng Perindopril effective in `real world' setting 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Perindopril (dpeaa)DE-He213 Oral Antihyperglycaemic Agent (dpeaa)DE-He213 Perindopril Erbumine (dpeaa)DE-He213 Aceon (dpeaa)DE-He213 Erbumine (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1341(2002), 1 vom: Juni, Seite 13-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1341 year:2002 number:1 month:06 pages:13-15 https://dx.doi.org/10.2165/00128413-200213410-00024 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1341 2002 1 06 13-15
allfieldsSound	10.2165/00128413-200213410-00024 doi (DE-627)SPR035130539 (SPR)00128413-200213410-00024-e DE-627 ger DE-627 rakwb eng Perindopril effective in `real world' setting 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Perindopril (dpeaa)DE-He213 Oral Antihyperglycaemic Agent (dpeaa)DE-He213 Perindopril Erbumine (dpeaa)DE-He213 Aceon (dpeaa)DE-He213 Erbumine (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1341(2002), 1 vom: Juni, Seite 13-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1341 year:2002 number:1 month:06 pages:13-15 https://dx.doi.org/10.2165/00128413-200213410-00024 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1341 2002 1 06 13-15
language	English
source	Enthalten in Inpharma weekly 1341(2002), 1 vom: Juni, Seite 13-15 volume:1341 year:2002 number:1 month:06 pages:13-15
sourceStr	Enthalten in Inpharma weekly 1341(2002), 1 vom: Juni, Seite 13-15 volume:1341 year:2002 number:1 month:06 pages:13-15
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Perindopril Oral Antihyperglycaemic Agent Perindopril Erbumine Aceon Erbumine
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2002-06-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035130539
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035130539</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519142030.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200213410-00024</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035130539</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200213410-00024-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Perindopril effective in `real world' setting</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2002</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2002</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Perindopril</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oral Antihyperglycaemic Agent</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Perindopril Erbumine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Aceon</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Erbumine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1341(2002), 1 vom: Juni, Seite 13-15</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1341</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:1</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:13-15</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200213410-00024</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1341</subfield><subfield code="j">2002</subfield><subfield code="e">1</subfield><subfield code="c">06</subfield><subfield code="h">13-15</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Perindopril effective in `real world' setting Perindopril (dpeaa)DE-He213 Oral Antihyperglycaemic Agent (dpeaa)DE-He213 Perindopril Erbumine (dpeaa)DE-He213 Aceon (dpeaa)DE-He213 Erbumine (dpeaa)DE-He213
topic	misc Perindopril misc Oral Antihyperglycaemic Agent misc Perindopril Erbumine misc Aceon misc Erbumine
spellingShingle	misc Perindopril misc Oral Antihyperglycaemic Agent misc Perindopril Erbumine misc Aceon misc Erbumine Perindopril effective in `real world' setting
topic_unstemmed	misc Perindopril misc Oral Antihyperglycaemic Agent misc Perindopril Erbumine misc Aceon misc Erbumine
topic_browse	misc Perindopril misc Oral Antihyperglycaemic Agent misc Perindopril Erbumine misc Aceon misc Erbumine
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Perindopril effective in `real world' setting
ctrlnum	(DE-627)SPR035130539 (SPR)00128413-200213410-00024-e
title_full	Perindopril effective in `real world' setting
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2002
contenttype_str_mv	txt
container_start_page	13
container_volume	1341
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200213410-00024
title_sort	perindopril effective in `real world' setting
title_auth	Perindopril effective in `real world' setting
abstract	© Adis International Ltd 2002
abstractGer	© Adis International Ltd 2002
abstract_unstemmed	© Adis International Ltd 2002
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Perindopril effective in `real world' setting
url	https://dx.doi.org/10.2165/00128413-200213410-00024
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200213410-00024
up_date	2024-07-03T13:42:27.170Z
_version_	1803565554387124224
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035130539</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519142030.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200213410-00024</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035130539</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200213410-00024-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Perindopril effective in `real world' setting</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2002</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2002</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Perindopril</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oral Antihyperglycaemic Agent</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Perindopril Erbumine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Aceon</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Erbumine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1341(2002), 1 vom: Juni, Seite 13-15</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1341</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:1</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:13-15</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200213410-00024</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1341</subfield><subfield code="j">2002</subfield><subfield code="e">1</subfield><subfield code="c">06</subfield><subfield code="h">13-15</subfield></datafield></record></collection>
score	7.402231

Nicht das Richtige dabei?

Schreiben Sie uns!

Perindopril effective in `real world' setting

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?